Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice-Reference-Cited by-同舟云学术

Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice

Published:2022-07 Issue: Volume:151 Page:113132
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wu Jiejie,Chen Ping,Ju Linjie,Gao Renhao,Li Silu,Huang Ziqian,Cheng Yiqiu,Gui Shuqi,Qiu Zhixia,Cheng Jun,Huang Fang

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. Epidemiology and natural history of nonalcoholic fatty liver disease;Satapathy;Semin. Liver Dis.,2015

2. Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis;Manne;Clin. Liver Dis.,2018

3. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease;Rotman;Gut,2017

4. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;Metabolism,2016

5. Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis;Finck;Diabetes,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review;Frontiers in Medicine;2024-03-25

2. Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-κB signaling pathway to relieve liver fibrosis;International Immunopharmacology;2024-03

3. Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways;Journal of Innate Immunity;2023-12-21

4. Targeted isolation, structural characterization and cytotoxicity evaluation of isoquinoline alkaloids from Corydalis saxicola;Journal of Molecular Structure;2023-12

5. Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3;Archives of Physiology and Biochemistry;2023-12